And no mention of them fixing our ceilings that were damaged by the first company they sent out. Don’t trust your largest investment, your home, to @ChoiceWarranty EVER because they do not care about their customers at all.
This is not how the system should work! I am symptomatic, sad, and frustrated. I would appreciate any help possible. Otherwise I will need to start chemo which will make my choice of future trials even more limited!
@AetnaHelp @Oncology_at_AZ @AstraZenecaUS@LUNGevity@lcrf_org
When I was diagnosed in 2013, osimertinib didn’t exist and I did very well on afatinib for almost 3 years. I am disadvantaged now because I have lived so long with #EGFR+ lung cancer and I am not eligible for trials that restrict to 1st line osi progression only.
More background: Selumetinib is co-developed by @AstraZeneca and @MSDInvents@Merck. It’s FDA approved for another indication & is being offered in the #ORCHARD trial in combo with osimertinib. I don’t qualify for the ORCHARD trial because I have taken another TKI prior to osi.
@kathygriffin Hope your surgery goes well and speedy recovery. I’m a 16 year lung cancer survivor! When you’re recovering look up https://t.co/rt4pTUSdrK and also #TheWhiteRibbonProject. Join us.